Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.0017671630017893e-51,183.98123980424143,21477.566900064325,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL22', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",5.564912713144974e-49,0,0,69
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,7.734057860683158e-33,61.83596214511041,4572.130906868122,"['COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'UCP3', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'NDUFA8', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5']",1.075034042634959e-30,0,0,48
3,Nonalcoholic fatty liver disease WP4396,2.6980018157006677e-23,18.275560772039647,949.7250744256205,"['NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'UQCRFS1', 'CYC1', 'COX8A', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",2.500148349215952e-21,0,0,43
4,Oxidative phosphorylation WP623,1.1161568958647826e-16,41.45104008117707,1522.5576371228833,"['NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFC2', 'NDUFC1', 'ATP5F1E', 'NDUFS6', 'NDUFS5']",7.75729042626024e-15,0,0,25
5,Mitochondrial complex I assembly model OXPHOS system WP4324,7.621150495715216e-15,98.79154078549848,3211.5004955603113,"['NDUFA8', 'NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFB11', 'NDUFB5', 'NDUFA3', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4']",4.23735967561766e-13,0,0,20
6,Mitochondrial CIV Assembly WP4922,2.426194681757214e-13,88.644578313253,2574.8840776497727,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX14']",1.124136869214176e-11,0,0,18
7,Mitochondrial complex III assembly WP4921,7.585802319143729e-07,inf,inf,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",3.0126472067456525e-05,0,0,8
8,Pyrimidine metabolism WP4022,0.00013857591711220337,5.941712204007286,52.78671931076356,"['NT5C', 'POLE4', 'POLD4', 'POLE3', 'NME2', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR2K', 'NME1', 'POLR2L']",0.004815513119649067,0,0,11
9,Cellular Proteostasis WP4918,0.0008795328114688807,inf,inf,"['VBP1', 'PFDN4', 'PFDN5', 'PFDN6']",0.027167791287594317,0,0,4
10,mRNA Processing WP411,0.0013533127915001625,9.668639053254438,63.863292478288734,"['LSM7', 'SNRPD1', 'NCBP2', 'SNRPE', 'SRSF9', 'LSM2']",0.03762209560370452,0,0,6
11,DNA Repair Pathways Full Network WP4946,0.0028972847112365076,5.64320987654321,32.978812917519136,"['POLE4', 'POLD4', 'DCLRE1C', 'NEIL2', 'CENPX', 'APEX1', 'POLE3']",0.07322228633852265,0,0,7
12,Base Excision Repair WP4752,0.005336808936839662,8.045297882816346,42.10206864692414,"['POLE4', 'POLD4', 'NEIL2', 'APEX1', 'POLE3']",0.12363607370345217,0,0,5
13,Proteasome Degradation WP183,0.010316195362435982,6.032127031019202,27.591191853103034,"['PSMD8', 'PSMB6', 'PSMD7', 'H2AFZ', 'PSMB10']",0.2206078700582464,0,0,5
14,Ciliary landscape WP4352,0.018468869033766808,2.4210134128166914,9.663883508829434,"['PSMD8', 'PSMD7', 'EXOSC4', 'NDUFA5', 'SSNA1', 'COPS7A', 'MYL6B', 'DYNLL1', 'COX6C', 'DCAF11', 'LSM4']",0.3667389708133695,0,0,11
15,Ferroptosis WP4313,0.02799003641713476,4.018956179222058,14.371412225316863,"['MAP1LC3A', 'GPX4', 'FTH1', 'SAT2', 'FTL']",0.5165471742052961,0,0,5
16,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.029729333767211284,inf,inf,"['ELOB', 'ELOC']",0.5165471742052961,0,0,2
17,Non-small cell lung cancer WP4255,0.04133022018678533,3.443764507280017,10.972389278420835,"['BAD', 'GADD45A', 'CYCS', 'BAX', 'HRAS']",0.6758706595250777,0,0,5
18,DNA Mismatch Repair WP531,0.06793106950759782,4.812960235640648,12.943309970144501,"['POLE4', 'POLD4', 'POLE3']",0.8442093130785987,0,0,3
19,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.06793106950759782,4.812960235640648,12.943309970144501,"['XBP1', 'MAP1LC3A', 'DDIT3']",0.8442093130785987,0,0,3
20,Nanomaterial induced apoptosis WP2507,0.06793106950759782,4.812960235640648,12.943309970144501,"['ENDOG', 'BAX', 'CYCS']",0.8442093130785987,0,0,3
21,Photodynamic therapy-induced unfolded protein response WP3613,0.06793106950759782,4.812960235640648,12.943309970144501,"['NARS', 'XBP1', 'DDIT3']",0.8442093130785987,0,0,3
22,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.07895482784188333,9.617647058823529,24.418045893369023,"['COX8A', 'COX5A']",0.8442093130785987,0,0,2
23,Dual hijack model of Vif in HIV infection WP3300,0.07895482784188333,9.617647058823529,24.418045893369023,"['ELOB', 'ELOC']",0.8442093130785987,0,0,2
24,Fatty acid transporters WP5061,0.07895482784188333,9.617647058823529,24.418045893369023,"['FABP6', 'FABP7']",0.8442093130785987,0,0,2
25,Peroxiredoxin 2 induced ovarian failure WP4873,0.07895482784188333,9.617647058823529,24.418045893369023,"['STAR', 'BAX']",0.8442093130785987,0,0,2
26,RalA downstream regulated genes WP2290,0.07895482784188333,9.617647058823529,24.418045893369023,"['RAC3', 'HRAS']",0.8442093130785987,0,0,2
27,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.10071337664910987,2.4084194977843425,5.528470724048776,"['BAD', 'GADD45A', 'RAC3', 'CYCS', 'BAX']",0.9638436570103538,0,0,5
28,Computational Model of Aerobic Glycolysis WP4629,0.10401190543277199,3.608615611192931,8.167198961145091,"['TPI1', 'ALDOA', 'PFKM']",0.9638436570103538,0,0,3
29,Eukaryotic Transcription Initiation WP405,0.10401190543277199,3.608615611192931,8.167198961145091,"['POLR2I', 'POLR2J', 'POLR2K']",0.9638436570103538,0,0,3
30,Nucleotide Excision Repair WP4753,0.10401190543277199,3.608615611192931,8.167198961145091,"['POLE4', 'POLD4', 'POLE3']",0.9638436570103538,0,0,3
31,Selenium Micronutrient Network WP15,0.11769338050637583,1.7363447251114412,3.7152090704486254,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOW', 'TXN', 'F2', 'SELENOK', 'SEPHS2', 'SELENOH']",0.9999846725168283,0,0,9
32,Pancreatic adenocarcinoma pathway WP4263,0.13766308657937476,2.4063421828908553,4.771646559280785,"['BAD', 'GADD45A', 'RAC3', 'BAX']",0.9999846725168283,0,0,4
33,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.14008173353991618,4.807352941176471,9.448992656182774,"['BAD', 'BAX']",0.9999846725168283,0,0,2
34,Methionine De Novo and Salvage Pathway WP3580,0.14008173353991618,4.807352941176471,9.448992656182774,"['AHCY', 'TXN']",0.9999846725168283,0,0,2
35,TP53 network WP1742,0.14583314261203675,2.8860088365243004,5.556410214520017,"['SUMO1', 'GADD45A', 'BAX']",0.9999846725168283,0,0,3
36,MET in type 1 papillary renal cell carcinoma WP4205,0.14583314261203675,2.8860088365243004,5.556410214520017,"['BAD', 'RPL11', 'HRAS']",0.9999846725168283,0,0,3
37,Glycerolipids and Glycerophospholipids WP4722,0.1725269405114377,inf,inf,['CDIPT'],0.9999846725168283,0,0,1
38,Glycerophospholipid Biosynthetic Pathway WP2533,0.1725269405114377,inf,inf,['CDIPT'],0.9999846725168283,0,0,1
39,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.1725269405114377,inf,inf,['MAP1LC3A'],0.9999846725168283,0,0,1
40,Mitochondrial CII Assembly WP4920,0.1725269405114377,inf,inf,['SDHAF1'],0.9999846725168283,0,0,1
41,Nanoparticle triggered autophagic cell death WP2509,0.1725269405114377,inf,inf,['MAP1LC3A'],0.9999846725168283,0,0,1
42,Non-homologous end joining WP438,0.1725269405114377,inf,inf,['DCLRE1C'],0.9999846725168283,0,0,1
43,Copper homeostasis WP3286,0.19199729970122573,2.4042709867452134,3.96770582891907,"['SCO2', 'COX17', 'ATOX1']",0.9999846725168283,0,0,3
44,BDNF-TrkB Signaling WP3676,0.20754993064454952,3.203921568627451,5.037792892837588,"['TRPC6', 'HRAS']",0.9999846725168283,0,0,2
45,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.20754993064454952,3.203921568627451,5.037792892837588,"['MAP1LC3A', 'FTL']",0.9999846725168283,0,0,2
46,Nucleotide metabolism WP404,0.20754993064454952,3.203921568627451,5.037792892837588,"['NME2', 'OAZ1']",0.9999846725168283,0,0,2
47,Osteoclast Signaling WP12,0.20754993064454952,3.203921568627451,5.037792892837588,"['AIMP2', 'ATP6V1G1']",0.9999846725168283,0,0,2
48,Sleep regulation WP3591,0.21126546302494648,1.9238938053097345,2.9909619147078867,"['AHCY', 'STAR', 'CRH', 'HCRTR1']",0.9999846725168283,0,0,4
49,Genotoxicity pathway WP4286,0.21126546302494648,1.9238938053097345,2.9909619147078867,"['RPS27', 'GADD45A', 'BLOC1S2', 'TRIAP1']",0.9999846725168283,0,0,4
50,Melanoma WP4685,0.21126546302494648,1.9238938053097345,2.9909619147078867,"['BAD', 'GADD45A', 'BAX', 'HRAS']",0.9999846725168283,0,0,4
51,Endometrial cancer WP4155,0.2514662226245218,1.7484580316438723,2.4136529487701903,"['BAD', 'GADD45A', 'BAX', 'HRAS']",0.9999846725168283,0,0,4
52,Serotonin and anxiety WP3947,0.2773593617798442,2.4022058823529413,3.0806879833725502,"['POMC', 'CRH']",0.9999846725168283,0,0,2
53,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.2773593617798442,2.4022058823529413,3.0806879833725502,"['H3F3B', 'H2AFZ']",0.9999846725168283,0,0,2
54,Histone Modifications WP2369,0.2773593617798442,2.4022058823529413,3.0806879833725502,"['SET', 'H3F3B']",0.9999846725168283,0,0,2
55,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.2773593617798442,2.4022058823529413,3.0806879833725502,"['STAR', 'HRAS']",0.9999846725168283,0,0,2
56,p38 MAPK Signaling Pathway WP400,0.2773593617798442,2.4022058823529413,3.0806879833725502,"['DDIT3', 'HRAS']",0.9999846725168283,0,0,2
57,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.2773593617798442,2.4022058823529413,3.0806879833725502,"['BAD', 'HRAS']",0.9999846725168283,0,0,2
58,Modulators of TCR signaling and T cell activation WP5072,0.293065539878349,1.6022615535889873,1.9665501531923786,"['FIBP', 'NDUFB10', 'ELOB', 'RNF7']",0.9999846725168283,0,0,4
59,The alternative pathway of fetal androgen synthesis WP4524,0.3153244910142911,4.8017621145374445,5.541968342678162,['STAR'],0.9999846725168283,0,0,1
60,Fatty acid beta-oxidation WP143,0.3153244910142911,4.8017621145374445,5.541968342678162,['TPI1'],0.9999846725168283,0,0,1
61,Immune response to tuberculosis WP4197,0.3153244910142911,4.8017621145374445,5.541968342678162,['IFIT3'],0.9999846725168283,0,0,1
62,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.3153244910142911,4.8017621145374445,5.541968342678162,['AHCY'],0.9999846725168283,0,0,1
63,Nanoparticle triggered regulated necrosis WP2513,0.3153244910142911,4.8017621145374445,5.541968342678162,['FTL'],0.9999846725168283,0,0,1
64,Nanoparticle-mediated activation of receptor signaling WP2643,0.3153244910142911,4.8017621145374445,5.541968342678162,['HRAS'],0.9999846725168283,0,0,1
65,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.3153244910142911,4.8017621145374445,5.541968342678162,['BAX'],0.9999846725168283,0,0,1
66,Androgen receptor signaling pathway WP138,0.3354475748765532,1.4785568413886998,1.6150122526703974,"['SUMO1', 'BAG1', 'DSTN', 'STUB1']",0.9999846725168283,0,0,4
67,Amyotrophic lateral sclerosis (ALS) WP2447,0.3466983315296028,1.9211764705882353,2.0351026939469157,"['BAD', 'BAX']",0.9999846725168283,0,0,2
68,Cori Cycle WP1946,0.3466983315296028,1.9211764705882353,2.0351026939469157,"['TPI1', 'ALDOA']",0.9999846725168283,0,0,2
69,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.3466983315296028,1.9211764705882353,2.0351026939469157,"['BANF1', 'HRAS']",0.9999846725168283,0,0,2
70,IL-18 signaling pathway WP4754,0.36780142818993117,1.1576426950119028,1.1578882122253091,"['NRN1', 'IMP3', 'BAD', 'COX17', 'NDUFC1', 'BPGM', 'RND2', 'NACA', 'TMSB4X', 'CYCS', 'BAX', 'PTPN7', 'ITM2C']",0.9999846725168283,0,0,13
71,16p11.2 proximal deletion syndrome WP4949,0.39450342219878926,1.4407952871870398,1.3401232665549319,"['ALDOA', 'SEZ6L2', 'CDIPT']",0.9999846725168283,0,0,3
72,Oxidative Damage WP3941,0.39450342219878926,1.4407952871870398,1.3401232665549319,"['BAD', 'GADD45A', 'CYCS']",0.9999846725168283,0,0,3
73,CAMKK2  Pathway WP4874,0.4136533721691671,1.6004901960784315,1.4127957831167408,"['FIS1', 'MAP1LC3A']",0.9999846725168283,0,0,2
74,Type 2 papillary renal cell carcinoma WP4241,0.4136533721691671,1.6004901960784315,1.4127957831167408,"['ELOB', 'ELOC']",0.9999846725168283,0,0,2
75,Unfolded protein response WP4925,0.4136533721691671,1.6004901960784315,1.4127957831167408,"['XBP1', 'DDIT3']",0.9999846725168283,0,0,2
76,Vitamin D-sensitive calcium signaling in depression WP4698,0.4136533721691671,1.6004901960784315,1.4127957831167408,"['GPX4', 'PVALB']",0.9999846725168283,0,0,2
77,DNA Replication WP466,0.4136533721691671,1.6004901960784315,1.4127957831167408,"['POLD4', 'UBA52']",0.9999846725168283,0,0,2
78,Genes related to primary cilium development (based on CRISPR) WP4536,0.4136533721691671,1.6004901960784315,1.4127957831167408,"['TMEM17', 'DYNLL1']",0.9999846725168283,0,0,2
79,Acute viral myocarditis WP4298,0.4203574741576796,1.28062930186824,1.109857129315005,"['ENDOG', 'RAC3', 'CYCS', 'BAX']",0.9999846725168283,0,0,4
80,Serotonin and anxiety-related events WP3944,0.4335092639784877,2.4001468428781205,2.0061438081749934,['CRH'],0.9999846725168283,0,0,1
81,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.4335092639784877,2.4001468428781205,2.0061438081749934,['IDH3B'],0.9999846725168283,0,0,1
82,Biomarkers for pyrimidine metabolism disorders WP4584,0.4335092639784877,2.4001468428781205,2.0061438081749934,['NT5C'],0.9999846725168283,0,0,1
83,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.4335092639784877,2.4001468428781205,2.0061438081749934,['SST'],0.9999846725168283,0,0,1
84,Trans-sulfuration and one-carbon metabolism WP2525,0.4335092639784877,2.4001468428781205,2.0061438081749934,['AHCY'],0.9999846725168283,0,0,1
85,Trans-sulfuration pathway WP2333,0.4335092639784877,2.4001468428781205,2.0061438081749934,['AHCY'],0.9999846725168283,0,0,1
86,"COVID-19, thrombosis and anticoagulation WP4927",0.4335092639784877,2.4001468428781205,2.0061438081749934,['F2'],0.9999846725168283,0,0,1
87,Cysteine and methionine catabolism WP4504,0.4335092639784877,2.4001468428781205,2.0061438081749934,['AHCY'],0.9999846725168283,0,0,1
88,Glycosylation and related congenital defects WP4521,0.4335092639784877,2.4001468428781205,2.0061438081749934,['DPM3'],0.9999846725168283,0,0,1
89,HIF1A and PPARG regulation of glycolysis WP2456,0.4335092639784877,2.4001468428781205,2.0061438081749934,['TPI1'],0.9999846725168283,0,0,1
90,Homologous recombination WP186,0.4335092639784877,2.4001468428781205,2.0061438081749934,['POLD4'],0.9999846725168283,0,0,1
91,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.4335092639784877,2.4001468428781205,2.0061438081749934,['HRAS'],0.9999846725168283,0,0,1
92,Interleukin-11 Signaling Pathway WP2332,0.4335092639784877,2.4001468428781205,2.0061438081749934,['HRAS'],0.9999846725168283,0,0,1
93,Iron metabolism in placenta WP2007,0.4335092639784877,2.4001468428781205,2.0061438081749934,['FTH1'],0.9999846725168283,0,0,1
94,MTHFR deficiency WP4288,0.4335092639784877,2.4001468428781205,2.0061438081749934,['CYCS'],0.9999846725168283,0,0,1
95,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.4335092639784877,2.4001468428781205,2.0061438081749934,['EIF1'],0.9999846725168283,0,0,1
96,Purine metabolism and related disorders WP4224,0.4335092639784877,2.4001468428781205,2.0061438081749934,['APRT'],0.9999846725168283,0,0,1
97,Purine metabolism WP4792,0.4335092639784877,2.4001468428781205,2.0061438081749934,['APRT'],0.9999846725168283,0,0,1
98,Pyrimidine metabolism and related diseases WP4225,0.4335092639784877,2.4001468428781205,2.0061438081749934,['NT5C'],0.9999846725168283,0,0,1
99,Senescence and Autophagy in Cancer WP615,0.43766297769505025,1.200516986706056,0.991994535808846,"['GABARAPL2', 'GABARAPL1', 'MAP1LC3A', 'HRAS', 'GABARAP']",0.9999846725168283,0,0,5
100,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.44447739190922264,1.3094122372472887,1.0617448831845,"['APEX1', 'HRAS', 'MYL12B']",0.9999846725168283,0,0,3
101,7q11.23 copy number variation syndrome WP4932,0.4619424661794392,1.200221238938053,0.9269487794156113,"['ATP5MC2', 'ATP5MC3', 'ATP5F1E', 'ATP5MC1']",0.9999846725168283,0,0,4
102,VEGFA-VEGFR2 Signaling Pathway WP3888,0.4672300408592423,1.0488028987014788,0.7980693126979763,"['SET', 'SDF2L1', 'SSR4', 'ARPC5L', 'SARS', 'TXN', 'RPL10A', 'RPL7', 'RPL18A', 'TMSB4X', 'RPLP2', 'CYCS', 'RPL27', 'RPL26', 'ELOC', 'ATP6V1E1', 'ALDOA', 'TMSB10', 'HRAS']",0.9999846725168283,0,0,19
103,Integrated breast cancer pathway WP1984,0.4740265507493733,1.142997819511852,0.8532386649799536,"['GADD45A', 'BAD', 'BAX', 'PHB', 'FAU']",0.9999846725168283,0,0,5
104,DNA IR-double strand breaks and cellular response via ATM WP3959,0.4769836493508705,1.3714285714285714,1.0152316344297891,"['DCLRE1C', 'BAX']",0.9999846725168283,0,0,2
105,Integrated Cancer Pathway WP1971,0.4769836493508705,1.3714285714285714,1.0152316344297891,"['BAD', 'BAX']",0.9999846725168283,0,0,2
106,Kit receptor signaling pathway WP304,0.4769836493508705,1.3714285714285714,1.0152316344297891,"['BAD', 'HRAS']",0.9999846725168283,0,0,2
107,NO/cGMP/PKG mediated Neuroprotection WP4008,0.4769836493508705,1.3714285714285714,1.0152316344297891,"['BAD', 'CYCS']",0.9999846725168283,0,0,2
108,PPAR signaling pathway WP3942,0.4769836493508705,1.3714285714285714,1.0152316344297891,"['FABP6', 'FABP7']",0.9999846725168283,0,0,2
109,G Protein Signaling Pathways WP35,0.4927301612953731,1.1999263622974963,0.8493001936535194,"['GNG10', 'GNG3', 'HRAS']",0.9999846725168283,0,0,3
110,Leptin signaling pathway WP2034,0.4927301612953731,1.1999263622974963,0.8493001936535194,"['BAD', 'BAX', 'HRAS']",0.9999846725168283,0,0,3
111,DNA damage response (only ATM dependent) WP710,0.5024321821012624,1.1292729481173,0.7772724824474703,"['BAD', 'RAC3', 'BAX', 'HRAS']",0.9999846725168283,0,0,4
112,Proximal tubule transport WP4917,0.5024321821012624,1.1292729481173,0.7772724824474703,"['ATP6V1G1', 'SLC7A9', 'ATP6V1E1', 'ATP6V1F']",0.9999846725168283,0,0,4
113,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.5313183779673647,1.5996084189916788,1.0115825354694088,['HRAS'],0.9999846725168283,0,0,1
114,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.5313183779673647,1.5996084189916788,1.0115825354694088,['DLL3'],0.9999846725168283,0,0,1
115,Type II diabetes mellitus WP1584,0.5313183779673647,1.5996084189916788,1.0115825354694088,['SURF1'],0.9999846725168283,0,0,1
116,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.5313183779673647,1.5996084189916788,1.0115825354694088,['H3F3B'],0.9999846725168283,0,0,1
117,Energy Metabolism WP1541,0.5313183779673647,1.5996084189916788,1.0115825354694088,['UCP3'],0.9999846725168283,0,0,1
118,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.5313183779673647,1.5996084189916788,1.0115825354694088,['MAP1LC3A'],0.9999846725168283,0,0,1
119,Gastric acid production WP2596,0.5313183779673647,1.5996084189916788,1.0115825354694088,['CCK'],0.9999846725168283,0,0,1
120,Genes targeted by miRNAs in adipocytes WP1992,0.5313183779673647,1.5996084189916788,1.0115825354694088,['TMSB4X'],0.9999846725168283,0,0,1
121,Glutathione metabolism WP100,0.5313183779673647,1.5996084189916788,1.0115825354694088,['GPX4'],0.9999846725168283,0,0,1
122,Intraflagellar transport proteins binding to dynein WP4532,0.5313183779673647,1.5996084189916788,1.0115825354694088,['DYNLL1'],0.9999846725168283,0,0,1
123,miRNA regulation of p53 pathway in prostate cancer WP3982,0.5313183779673647,1.5996084189916788,1.0115825354694088,['BAX'],0.9999846725168283,0,0,1
124,NOTCH1 regulation of endothelial cell calcification WP3413,0.5313183779673647,1.5996084189916788,1.0115825354694088,['DLL3'],0.9999846725168283,0,0,1
125,NRF2-ARE regulation WP4357,0.5313183779673647,1.5996084189916788,1.0115825354694088,['AIMP2'],0.9999846725168283,0,0,1
126,Overview of nanoparticle effects WP3287,0.5313183779673647,1.5996084189916788,1.0115825354694088,['BAX'],0.9999846725168283,0,0,1
127,PDGFR-beta pathway WP3972,0.5313183779673647,1.5996084189916788,1.0115825354694088,['HRAS'],0.9999846725168283,0,0,1
128,Phytochemical activity on NRF2 transcriptional activation WP3,0.5313183779673647,1.5996084189916788,1.0115825354694088,['AIMP2'],0.9999846725168283,0,0,1
129,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.5313183779673647,1.5996084189916788,1.0115825354694088,['ANAPC11'],0.9999846725168283,0,0,1
130,Translation Factors WP107,0.5359463172353929,1.1996323529411765,0.7482362235133051,"['EEF1B2', 'EIF1']",0.9999846725168283,0,0,2
131,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.5388065862936868,1.1072844681092104,0.6847431765247117,"['BAD', 'BAX', 'HRAS']",0.9999846725168283,0,0,3
132,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.5388065862936868,1.1072844681092104,0.6847431765247117,"['PSMD8', 'PSMD7', 'STUB1']",0.9999846725168283,0,0,3
133,TNF-alpha signaling pathway WP231,0.5415248704715826,1.0662078007210751,0.6539759174966278,"['BAD', 'BAX', 'TXN', 'HRAS']",0.9999846725168283,0,0,4
134,Regulation of Actin Cytoskeleton WP51,0.5775029285387137,0.9991999015263417,0.5486024780577584,"['FGF17', 'TMSB4X', 'BRK1', 'RAC3', 'F2']",0.9999846725168283,0,0,5
135,Pathways in clear cell renal cell carcinoma WP4018,0.5823834884495592,1.0278771302335368,0.55569723850583,"['TPI1', 'ALDOA', 'PFKM']",0.9999846725168283,0,0,3
136,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.5823834884495592,1.0278771302335368,0.55569723850583,"['BAD', 'BAX', 'HRAS']",0.9999846725168283,0,0,3
137,3q29 copy number variation syndrome WP4906,0.5901619923348375,1.0660130718954248,0.5621707523482897,"['NCBP2', 'DYNLL1']",0.9999846725168283,0,0,2
138,Nephrotic syndrome WP4758,0.5901619923348375,1.0660130718954248,0.5621707523482897,"['TRPC6', 'PAX2']",0.9999846725168283,0,0,2
139,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.5901619923348375,1.0660130718954248,0.5621707523482897,"['IGFBP2', 'BAX']",0.9999846725168283,0,0,2
140,Apoptosis Modulation by HSP70 WP384,0.6122604244795381,1.199339207048458,0.5883928847365731,['CYCS'],0.9999846725168283,0,0,1
141,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.6122604244795381,1.199339207048458,0.5883928847365731,['CCK'],0.9999846725168283,0,0,1
142,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.6122604244795381,1.199339207048458,0.5883928847365731,['STAR'],0.9999846725168283,0,0,1
143,Galanin receptor pathway WP4970,0.6122604244795381,1.199339207048458,0.5883928847365731,['POMC'],0.9999846725168283,0,0,1
144,ID signaling pathway WP53,0.6122604244795381,1.199339207048458,0.5883928847365731,['PAX2'],0.9999846725168283,0,0,1
145,IL-7 signaling pathway WP205,0.6122604244795381,1.199339207048458,0.5883928847365731,['BAD'],0.9999846725168283,0,0,1
146,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.6122604244795381,1.199339207048458,0.5883928847365731,['BAX'],0.9999846725168283,0,0,1
147,MAPK Cascade WP422,0.6122604244795381,1.199339207048458,0.5883928847365731,['HRAS'],0.9999846725168283,0,0,1
148,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.6122604244795381,1.199339207048458,0.5883928847365731,['SCO2'],0.9999846725168283,0,0,1
149,Alzheimer's disease WP2059,0.6232508539028406,0.9590574374079529,0.4534482896140097,"['ATP5MD', 'BAD', 'CYCS']",0.9999846725168283,0,0,3
150,DNA damage response WP707,0.6232508539028406,0.9590574374079529,0.4534482896140097,"['GADD45A', 'CYCS', 'BAX']",0.9999846725168283,0,0,3
151,Folate Metabolism WP176,0.6232508539028406,0.9590574374079529,0.4534482896140097,"['AHCY', 'GPX4', 'F2']",0.9999846725168283,0,0,3
152,miRNA regulation of DNA damage response WP1530,0.6232508539028406,0.9590574374079529,0.4534482896140097,"['GADD45A', 'CYCS', 'BAX']",0.9999846725168283,0,0,3
153,Circadian rhythm related genes WP3594,0.6305860855124031,0.9318930041152264,0.42970108055075384,"['AHCY', 'STAR', 'CRH', 'AVP', 'RPS27A', 'UBA52', 'HCRTR1']",0.9999846725168283,0,0,7
154,Aryl Hydrocarbon Receptor Pathway WP2873,0.639511728650075,0.9591176470588235,0.42877384891304077,"['AIP', 'BAX']",0.9999846725168283,0,0,2
155,Cytosolic DNA-sensing pathway WP4655,0.639511728650075,0.9591176470588235,0.42877384891304077,"['POLR2K', 'POLR2L']",0.9999846725168283,0,0,2
156,p53 transcriptional gene network WP4963,0.639511728650075,0.9591176470588235,0.42877384891304077,"['GADD45A', 'BAX']",0.9999846725168283,0,0,2
157,Small cell lung cancer WP4658,0.661293329525562,0.898840206185567,0.37172235239229556,"['GADD45A', 'CYCS', 'BAX']",0.9999846725168283,0,0,3
158,Corticotropin-releasing hormone signaling pathway WP2355,0.661293329525562,0.898840206185567,0.37172235239229556,"['POMC', 'STAR', 'CRH']",0.9999846725168283,0,0,3
159,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.6792405700763056,0.9591776798825257,0.37099066017009774,['HRAS'],0.9999846725168283,0,0,1
160,ERK Pathway in Huntington's Disease WP3853,0.6792405700763056,0.9591776798825257,0.37099066017009774,['HRAS'],0.9999846725168283,0,0,1
161,Ethanol effects on histone modifications WP3996,0.6792405700763056,0.9591776798825257,0.37099066017009774,['AHCY'],0.9999846725168283,0,0,1
162,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6792405700763056,0.9591776798825257,0.37099066017009774,['HRAS'],0.9999846725168283,0,0,1
163,Gastric Cancer Network 2 WP2363,0.6792405700763056,0.9591776798825257,0.37099066017009774,['S100A6'],0.9999846725168283,0,0,1
164,GDNF/RET signaling axis WP4830,0.6792405700763056,0.9591776798825257,0.37099066017009774,['PAX2'],0.9999846725168283,0,0,1
165,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.6792405700763056,0.9591776798825257,0.37099066017009774,['SUPT4H1'],0.9999846725168283,0,0,1
166,miRNA regulation of prostate cancer signaling pathways WP3981,0.6792405700763056,0.9591776798825257,0.37099066017009774,['BAD'],0.9999846725168283,0,0,1
167,One-carbon metabolism and related pathways WP3940,0.6792405700763056,0.9591776798825257,0.37099066017009774,['GPX4'],0.9999846725168283,0,0,1
168,One-carbon metabolism WP241,0.6792405700763056,0.9591776798825257,0.37099066017009774,['AHCY'],0.9999846725168283,0,0,1
169,Parkinson's disease pathway WP2371,0.6792405700763056,0.9591776798825257,0.37099066017009774,['CYCS'],0.9999846725168283,0,0,1
170,"Relationship between inflammation, COX-2 and EGFR WP4483",0.6792405700763056,0.9591776798825257,0.37099066017009774,['HRAS'],0.9999846725168283,0,0,1
171,MAPK Signaling Pathway WP382,0.6800072033349335,0.8823001949317739,0.3402607357186476,"['DUSP4', 'FGF17', 'GADD45A', 'DDIT3', 'RAC3', 'PTPN7', 'HRAS']",0.9999846725168283,0,0,7
172,Aryl Hydrocarbon Receptor Netpath WP2586,0.6840586497025455,0.8716577540106952,0.33097857773573525,"['AIP', 'HRAS']",0.9999846725168283,0,0,2
173,IL-3 signaling pathway WP286,0.6840586497025455,0.8716577540106952,0.33097857773573525,"['BAD', 'HRAS']",0.9999846725168283,0,0,2
174,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.6840586497025455,0.8716577540106952,0.33097857773573525,"['NDUFA13', 'ACAP1']",0.9999846725168283,0,0,2
175,Glycolysis and Gluconeogenesis WP534,0.6964728589164677,0.8457073551069912,0.3059147229696537,"['TPI1', 'ALDOA', 'PFKM']",0.9999846725168283,0,0,3
176,Apoptosis WP254,0.7288129356064349,0.7984781541482573,0.25258912925359517,"['BAD', 'CYCS', 'BAX']",0.9999846725168283,0,0,3
177,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.7288129356064349,0.7984781541482573,0.25258912925359517,"['POMC', 'BAD', 'HRAS']",0.9999846725168283,0,0,3
178,Insulin Signaling WP481,0.7288129356064349,0.7984781541482573,0.25258912925359517,"['XBP1', 'HRAS', 'PFKM']",0.9999846725168283,0,0,3
179,Signaling of Hepatocyte Growth Factor Receptor WP313,0.7346642084675812,0.7990699951052374,0.2463866353806319,['HRAS'],0.9999846725168283,0,0,1
180,ATM Signaling Network in Development and Disease  WP3878,0.7346642084675812,0.7990699951052374,0.2463866353806319,['DCLRE1C'],0.9999846725168283,0,0,1
181,Transcriptional cascade regulating adipogenesis WP4211,0.7346642084675812,0.7990699951052374,0.2463866353806319,['DDIT3'],0.9999846725168283,0,0,1
182,Endothelin Pathways WP2197,0.7346642084675812,0.7990699951052374,0.2463866353806319,['RIIAD1'],0.9999846725168283,0,0,1
183,Fluoropyrimidine Activity WP1601,0.7346642084675812,0.7990699951052374,0.2463866353806319,['UPP2'],0.9999846725168283,0,0,1
184,GABA receptor Signaling WP4159,0.7346642084675812,0.7990699951052374,0.2463866353806319,['SLC32A1'],0.9999846725168283,0,0,1
185,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7346642084675812,0.7990699951052374,0.2463866353806319,['DDIT3'],0.9999846725168283,0,0,1
186,Nephrogenesis WP5052,0.7346642084675812,0.7990699951052374,0.2463866353806319,['PAX2'],0.9999846725168283,0,0,1
187,PDGF Pathway WP2526,0.7346642084675812,0.7990699951052374,0.2463866353806319,['HRAS'],0.9999846725168283,0,0,1
188,SARS-CoV-2 mitochondrial interactions WP5038,0.7346642084675812,0.7990699951052374,0.2463866353806319,['PHB'],0.9999846725168283,0,0,1
189,Hepatitis B infection WP4666,0.7372566446728679,0.798180924287119,0.24330088559973406,"['BAD', 'CYCS', 'BAX', 'HRAS']",0.9999846725168283,0,0,4
190,Ras signaling WP4223,0.7466731040963516,0.7978828163466273,0.2330837528190031,"['GNG10', 'GNG3', 'BAD', 'RAC3', 'HRAS']",0.9999846725168283,0,0,5
191,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.759567020953644,0.7371040723981901,0.20270857127289274,"['BEX3', 'RNF7']",0.9999846725168283,0,0,2
192,ErbB signaling pathway WP673,0.759567020953644,0.7371040723981901,0.20270857127289274,"['BAD', 'HRAS']",0.9999846725168283,0,0,2
193,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.759567020953644,0.7371040723981901,0.20270857127289274,"['TRPC6', 'PAX2']",0.9999846725168283,0,0,2
194,Alpha 6 Beta 4 signaling pathway WP244,0.7805228305132688,0.6847073631214601,0.16966451962757795,['HRAS'],0.9999846725168283,0,0,1
195,Tumor suppressor activity of SMARCB1 WP4204,0.7805228305132688,0.6847073631214601,0.16966451962757795,['H3F3B'],0.9999846725168283,0,0,1
196,IL-2 signaling pathway WP49,0.7805228305132688,0.6847073631214601,0.16966451962757795,['HRAS'],0.9999846725168283,0,0,1
197,IL1 and megakaryocytes in obesity WP2865,0.7805228305132688,0.6847073631214601,0.16966451962757795,['F2'],0.9999846725168283,0,0,1
198,Joubert Syndrome WP4656,0.7805228305132688,0.6847073631214601,0.16966451962757795,['TMEM17'],0.9999846725168283,0,0,1
199,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.7805228305132688,0.6847073631214601,0.16966451962757795,['PIN1'],0.9999846725168283,0,0,1
200,Regulation of Microtubule Cytoskeleton WP2038,0.7805228305132688,0.6847073631214601,0.16966451962757795,['PARD6A'],0.9999846725168283,0,0,1
201,TGF-beta Signaling Pathway WP366,0.7852949209738679,0.7181885125184094,0.17358324493533844,"['PARD6A', 'CITED1', 'SUMO1']",0.9999846725168283,0,0,3
202,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.7911041778429442,0.6842436974789916,0.16033582584656478,"['IFI27L2', 'HRAS']",0.9999846725168283,0,0,2
203,Canonical and non-canonical Notch signaling WP3845,0.8184651589424722,0.598935389133627,0.11998140243642007,['DLL3'],0.9999846725168283,0,0,1
204,Fas ligand pathway and stress induction of heat shock proteins WP314,0.8184651589424722,0.598935389133627,0.11998140243642007,['CYCS'],0.9999846725168283,0,0,1
205,IL-6 signaling pathway WP364,0.8184651589424722,0.598935389133627,0.11998140243642007,['BAD'],0.9999846725168283,0,0,1
206,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.8184651589424722,0.598935389133627,0.11998140243642007,['BAX'],0.9999846725168283,0,0,1
207,Exercise-induced Circadian Regulation WP410,0.8189335542550898,0.6384313725490196,0.12752815341754137,"['SUMO1', 'UCP3']",0.9999846725168283,0,0,2
208,EGF/EGFR signaling pathway WP437,0.8316767175014883,0.6524969875485339,0.12026268179413233,"['NDUFA13', 'NEDD8', 'HRAS']",0.9999846725168283,0,0,3
209,Breast cancer pathway WP4262,0.8445966539033115,0.682844481958219,0.11532976870968714,"['FGF17', 'GADD45A', 'BAX', 'HRAS', 'DLL3']",0.9999846725168283,0,0,5
210,ATM Signaling Pathway WP2516,0.8498560721124868,0.5322238538097569,0.0865865784344284,['GADD45A'],0.9999846725168283,0,0,1
211,Bladder cancer WP2828,0.8498560721124868,0.5322238538097569,0.0865865784344284,['HRAS'],0.9999846725168283,0,0,1
212,Blood Clotting Cascade WP272,0.8498560721124868,0.5322238538097569,0.0865865784344284,['F2'],0.9999846725168283,0,0,1
213,Cardiac Progenitor Differentiation WP2406,0.8498560721124868,0.5322238538097569,0.0865865784344284,['MESP1'],0.9999846725168283,0,0,1
214,Development of ureteric collection system WP5053,0.8498560721124868,0.5322238538097569,0.0865865784344284,['PAX2'],0.9999846725168283,0,0,1
215,Notch Signaling WP268,0.8498560721124868,0.5322238538097569,0.0865865784344284,['DLL3'],0.9999846725168283,0,0,1
216,Ciliopathies WP4803,0.8691803043613329,0.5977540500736377,0.08380792150084508,"['TMEM17', 'CCNQ', 'CCDC28B']",0.9999846725168283,0,0,3
217,Endoderm differentiation WP2853,0.8691803043613329,0.5977540500736377,0.08380792150084508,"['DUSP4', 'TCEAL2', 'NME1']",0.9999846725168283,0,0,3
218,Imatinib and Chronic Myeloid Leukemia WP3640,0.8758254111244974,0.4788546255506608,0.06349062144168187,['GADD45A'],0.9999846725168283,0,0,1
219,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.8758254111244974,0.4788546255506608,0.06349062144168187,['BAX'],0.9999846725168283,0,0,1
220,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.8758254111244974,0.4788546255506608,0.06349062144168187,['STAR'],0.9999846725168283,0,0,1
221,Apoptosis Modulation and Signaling WP1772,0.87746966897971,0.6166143305737939,0.08059944085936635,"['ENDOG', 'BAD', 'CYCS', 'BAX']",0.9999846725168283,0,0,4
222,Integrin-mediated Cell Adhesion WP185,0.8835222806255687,0.5315359477124183,0.0658247574167894,"['RAC3', 'HRAS']",0.9999846725168283,0,0,2
223,22q11.2 copy number variation syndrome WP4657,0.8850111037845115,0.5736671575846833,0.07007636177541811,"['RANBP1', 'MRPL40', 'THAP7']",0.9999846725168283,0,0,3
224,Synaptic Vesicle Pathway WP2267,0.8973084049553349,0.43518889333867306,0.04715517879709481,['SLC32A1'],0.9999846725168283,0,0,1
225,Genes controlling nephrogenesis WP4823,0.8973084049553349,0.43518889333867306,0.04715517879709481,['PAX2'],0.9999846725168283,0,0,1
226,Head and Neck Squamous Cell Carcinoma WP4674,0.8973084049553349,0.43518889333867306,0.04715517879709481,['HRAS'],0.9999846725168283,0,0,1
227,IL-4 signaling pathway WP395,0.8973084049553349,0.43518889333867306,0.04715517879709481,['BAD'],0.9999846725168283,0,0,1
228,MECP2 and Associated Rett Syndrome WP3584,0.8973084049553349,0.43518889333867306,0.04715517879709481,['SST'],0.9999846725168283,0,0,1
229,Notch Signaling Pathway Netpath WP61,0.8973084049553349,0.43518889333867306,0.04715517879709481,['DLL3'],0.9999846725168283,0,0,1
230,Pathways affected in adenoid cystic carcinoma WP3651,0.8973084049553349,0.43518889333867306,0.04715517879709481,['HRAS'],0.9999846725168283,0,0,1
231,ESC Pluripotency Pathways WP3931,0.899807425711609,0.503405572755418,0.053146796667132214,"['FGF17', 'HRAS']",0.9999846725168283,0,0,2
232,Chemokine signaling pathway WP3929,0.9116335775079952,0.5308460153820979,0.049112359737068886,"['GNG10', 'GNG3', 'HRAS']",0.9999846725168283,0,0,3
233,Complement system WP2806,0.9141609497316928,0.5616866215512754,0.050410604342364926,"['FKBP2', 'RPS19', 'CD59', 'TXN']",0.9999846725168283,0,0,4
234,AGE/RAGE pathway WP2324,0.9150791506172448,0.39880078316201667,0.03539146146103794,['CYCS'],0.9999846725168283,0,0,1
235,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9150791506172448,0.39880078316201667,0.03539146146103794,['HRAS'],0.9999846725168283,0,0,1
236,Oncostatin M Signaling Pathway WP2374,0.9150791506172448,0.39880078316201667,0.03539146146103794,['HRAS'],0.9999846725168283,0,0,1
237,Prolactin Signaling Pathway WP2037,0.9150791506172448,0.39880078316201667,0.03539146146103794,['HRAS'],0.9999846725168283,0,0,1
238,Thermogenesis WP4321,0.9297783413491489,0.3680108437817689,0.026794525032806184,['HRAS'],0.9999846725168283,0,0,1
239,Glioblastoma signaling pathways WP2261,0.9297783413491489,0.3680108437817689,0.026794525032806184,['HRAS'],0.9999846725168283,0,0,1
240,Pathogenic Escherichia coli infection WP2272,0.9297783413491489,0.3680108437817689,0.026794525032806184,['ARPC5L'],0.9999846725168283,0,0,1
241,Prostaglandin Synthesis and Regulation WP98,0.9297783413491489,0.3680108437817689,0.026794525032806184,['S100A6'],0.9999846725168283,0,0,1
242,Adipogenesis WP236,0.9411855793211712,0.477319587628866,0.02893269999524104,"['GADD45A', 'DDIT3', 'MIF']",0.9999846725168283,0,0,3
243,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9419362283783346,0.341619467170128,0.020434892444383932,['HRAS'],0.9999846725168283,0,0,1
244,TGF-beta Receptor Signaling WP560,0.9419362283783346,0.341619467170128,0.020434892444383932,['HRAS'],0.9999846725168283,0,0,1
245,White fat cell differentiation WP4149,0.9419362283783346,0.341619467170128,0.020434892444383932,['DDIT3'],0.9999846725168283,0,0,1
246,Prader-Willi and Angelman Syndrome WP3998,0.9419362283783346,0.341619467170128,0.020434892444383932,['POMC'],0.9999846725168283,0,0,1
247,Cell cycle WP179,0.945936447780161,0.4153452685421995,0.023084845219513754,"['GADD45A', 'ANAPC11']",0.9999846725168283,0,0,2
248,Gastrin signaling pathway WP4659,0.945936447780161,0.4153452685421995,0.023084845219513754,"['BAD', 'HRAS']",0.9999846725168283,0,0,2
249,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.9519916356649594,0.3187469407733725,0.015682040395735338,['TMSB4X'],0.9999846725168283,0,0,1
250,T-cell receptor (TCR) signaling pathway WP69,0.9519916356649594,0.3187469407733725,0.015682040395735338,['HRAS'],0.9999846725168283,0,0,1
251,G1 to S cell cycle control WP45,0.9519916356649594,0.3187469407733725,0.015682040395735338,['GADD45A'],0.9999846725168283,0,0,1
252,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9538096982492215,0.39791666666666664,0.018817918927597946,"['BAD', 'HRAS']",0.9999846725168283,0,0,2
253,Vitamin B12 metabolism WP1533,0.960307704746174,0.29873348017621143,0.01209916005202033,['F2'],0.9999846725168283,0,0,1
254,Male infertility WP4673,0.960307704746174,0.29873348017621143,0.01209916005202033,['PEX10'],0.9999846725168283,0,0,1
255,Pre-implantation embryo WP3527,0.960307704746174,0.29873348017621143,0.01209916005202033,['DDIT3'],0.9999846725168283,0,0,1
256,Focal Adhesion WP306,0.9688914958152474,0.453574940300604,0.014334169535520108,"['BAD', 'RAC3', 'HRAS', 'MYL12B']",0.9999846725168283,0,0,4
257,Myometrial relaxation and contraction pathways WP289,0.9688914958152474,0.453574940300604,0.014334169535520108,"['GNG3', 'IGFBP2', 'CRH', 'IGFBP6']",0.9999846725168283,0,0,4
258,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.971376807594944,0.3533769063180828,0.010262356751367163,"['HRAS', 'DLL3']",0.9999846725168283,0,0,2
259,Retinoblastoma gene in cancer WP2446,0.9728719605515342,0.2653777125142764,0.007298629594349892,['H2AFZ'],0.9999846725168283,0,0,1
260,NRF2 pathway WP2884,0.9748773948304256,0.39702994599901814,0.010101857151902715,"['FTH1', 'TXN', 'FTL']",0.9999846725168283,0,0,3
261,Peptide GPCRs WP24,0.9846776829103687,0.2272568351863506,0.0035090538915459693,['HCRTR1'],0.9999846725168283,0,0,1
262,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.988000966898466,0.3480728474442329,0.004201797087613145,"['SST', 'AVP', 'ALDOA']",0.9999846725168283,0,0,3
263,B Cell Receptor Signaling Pathway WP23,0.9895329378381084,0.20736768179786758,0.0021819698489968483,['HRAS'],0.9999846725168283,0,0,1
264,Microglia Pathogen Phagocytosis Pathway WP3937,0.9895329378381084,0.20736768179786758,0.0021819698489968483,['RAC3'],0.9999846725168283,0,0,1
265,Neural Crest Differentiation WP2064,0.9895329378381084,0.20736768179786758,0.0021819698489968483,['DLL3'],0.9999846725168283,0,0,1
266,Ectoderm Differentiation WP2858,0.9913494121597376,0.19866617719040627,0.001726055725603538,['LY6E'],0.9999846725168283,0,0,1
267,Complement and Coagulation Cascades WP558,0.9928509561725448,0.19066079295154184,0.0013679379361798893,['F2'],0.9999846725168283,0,0,1
268,Spinal Cord Injury WP2431,0.9943935581578168,0.3097585964013575,0.00174153002374598,"['GADD45A', 'APEX1', 'MIF']",0.9999846725168283,0,0,3
269,Osteoblast differentiation WP4787,0.9959658146495987,0.17007551919446193,0.0006875038612916974,['DLL3'],0.9999846725168283,0,0,1
270,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.996125694426929,0.36427678672878083,0.0014140606086297416,"['FGF17', 'GNG10', 'GNG3', 'BAD', 'HRAS']",0.9999846725168283,0,0,5
271,Mesodermal commitment pathway WP2857,0.9972455890379951,0.1586392559960842,0.00043756059358898784,['RPL38'],0.9999846725168283,0,0,1
272,Hippo-Merlin Signaling Dysregulation WP4541,0.9977241026614118,0.15347449197101037,0.00034969026850687217,['HRAS'],0.9999846725168283,0,0,1
273,PI3K-Akt signaling pathway WP4172,0.9980750097725681,0.3377294787929943,0.0006507524934326758,"['FGF17', 'GNG10', 'GNG3', 'BAD', 'HRAS']",0.9999846725168283,0,0,5
274,Metapathway biotransformation Phase I and II WP702,0.9984462066563621,0.1440840119254216,0.00022405088815542906,['GPX4'],0.9999846725168283,0,0,1
275,Vitamin D Receptor Pathway WP2877,0.9995795577385257,0.18207013574660633,7.656607655555704e-05,"['GADD45A', 'S100A6']",0.9999846725168283,0,0,2
276,Calcium Regulation in the Cardiac Cell WP536,0.9995908600596081,0.11861233480176211,4.853897388422088e-05,['GNG3'],0.9999846725168283,0,0,1
277,Nuclear Receptors Meta-Pathway WP2882,0.9998124978616345,0.2735220363436502,5.129077541983645e-05,"['FTH1', 'AIP', 'BAX', 'TXN', 'FTL']",0.9999846725168283,0,0,5
278,"GPCRs, Class A Rhodopsin-like WP455",0.9999846725168283,0.1306781045751634,2.002981799156818e-06,"['APLNR', 'HCRTR1']",0.9999846725168283,0,0,2
